Notice of Revisions to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
Notice NOT-OD-24-093 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 4, 2024 Category: Research Source Type: funding
Notice of Change to Application Due Date for PAS-21-270, "AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)"
Notice NOT-DA-24-022 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 4, 2024 Category: Research Source Type: funding
What Happens If a Due Date Falls on a Weekend?
When an application due date falls on a weekend (or Federal holiday, or Washington, DC area Federal office closure) the application deadline is automatically extended to the next business day. For example, the May 25, 2024 standard due date for some of our programs falls on a Saturday, which means it slides to Monday, May 27, 2024.
Note that January 25, 2025, the effective due date for many upcoming application and/or peer review changes, also falls on a Saturday and would slide to Monday, January 27, 2025 (see FAQ).
Learn more on our Submission Policies page. (Source: NIH Extramural Nexus)
Source: NIH Extramural Nexus - April 3, 2024 Category: Research Authors: NIH Staff Tags: You Ask, We Answer applications Grants policy Source Type: funding
Why Do I Sometimes Get Different RePORTER Results when Using Advanced Search vs. Quick Search?
Research Portfolio Online Reporting Tools Expenditures and Results (RePORTER) is an electronic tool that allows users to search a repository of both intramural and extramural NIH-funded research projects and publications and patents resulting from NIH funding. Users can query the system in two distinct ways, either via “Advanced Search” or “Quick Search.” But its worth noting there can be a difference in the query results depending on which approach is used.
As we first explained on this NIH Open Mike blog post, Quick Search is helpful for performing simple queries. Advanced Search allows you to use precisely de...
Source: NIH Extramural Nexus - April 3, 2024 Category: Research Authors: NIH Staff Tags: You Ask, We Answer Funding data RePORT RePORTER Source Type: funding
Termination of NOSI NOT-OD-22-191 - Administrative Supplements to NCATS CTSA Program T32/TL1 Institutional Training Program as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
Notice NOT-TR-24-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2024 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program T32/TL1 Institutional Training Program as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
Notice NOT-TR-24-017 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2024 Category: Research Source Type: funding
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-TR-24-023 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic studies would be supported. Therapeutic agents include small molecules, biologics or biotechnology-derived products. The goal of this NOFO is to spur therapeutic development for a variety of rare diseases by advancing projects to the point where t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2024 Category: Research Source Type: funding
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-25-009 from the NIH Guide for Grants and Contracts. This NOFO encourages applications from institutions that propose to establish research experiences in kidney technology development. Successful programs should include a collaborative capstone research or design project(s), innovative and/or ground-breaking technology development, multidisciplinary/interdisciplinary teamwork, education in entrepreneurship, product development and navigating regulatory pathways, and clinical immersion. The intent of this NOFO is to recruit undergraduate students as participants and to engage students from engi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2024 Category: Research Source Type: funding
Notice of Pre-Application Webinar for NOT-AG-24-004, "Notice of Special Interest (NOSI): U.S. Health in the International Perspective"
Notice NOT-AG-24-015 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2024 Category: Research Source Type: funding
Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional)
Funding Opportunity RFA-MH-25-190 from the NIH Guide for Grants and Contracts. The purpose of this phased Notice of Funding Opportunity (NOFO) is to create a pipeline to accelerate the development and early validation of predictive tools and/or biomarkers to inform individual-level treatment selection among two or more existing therapeutics for depression. This phased inter-agency program will be milestone-based and provide support from multi-disciplinary teams to address scientific, technical, clinical, regulatory, and commercialization requirements. In the first phase (UG3), investigators are expected to identify pote...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2024 Category: Research Source Type: funding
Notice of Participation of the Fogarty International Center (FIC) in the Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
Notice NOT-TW-24-004 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2024 Category: Research Source Type: funding
Notice of NICHD Participation in PAR-24-144, Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Notice NOT-HD-24-019 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2024 Category: Research Source Type: funding
Notice of NICHD Participation in PAR-24-145, Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
Notice NOT-HD-24-020 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2024 Category: Research Source Type: funding
Notice of NIDA Participation in RFA-OD-24-014, "Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)"
Notice NOT-DA-24-020 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2024 Category: Research Source Type: funding
Notice of NIAMS' Participation in "PAR-22-181, Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
Notice NOT-AR-24-014 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2024 Category: Research Source Type: funding
